PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset
Presentation Product Chemical substance Chapter Items dispensed
Insulin soluble bovine 100units/ml inj 10ml vials
0601011N0AAAAAA
Insulin soluble Soluble insulin (Neutral insulin) Endocrine System No data available
Insulin soluble bovine 100units/ml inj 3ml cartridges
0601011N0AAAYAY
Insulin soluble Soluble insulin (Neutral insulin) Endocrine System No data available
Insulin soluble human 100units/ml inj 1.5ml cartridges
0601011N0AAADAD
Insulin soluble Soluble insulin (Neutral insulin) Endocrine System No data available
Insulin soluble human 100units/ml inj 3ml pf dispos dev
0601011N0AAAMAM
Insulin soluble Soluble insulin (Neutral insulin) Endocrine System No data available
Insulin soluble human 100units/ml inj 5ml vials
0601011N0AAAWAW
Insulin soluble Soluble insulin (Neutral insulin) Endocrine System No data available
Insulin soluble porcine 100units/ml inj 1.5ml cartridges
0601011N0AAAUAU
Insulin soluble Soluble insulin (Neutral insulin) Endocrine System No data available
Insulin soluble porcine 100units/ml inj 3ml cartridges
0601011N0AAAZAZ
Insulin soluble Soluble insulin (Neutral insulin) Endocrine System No data available
Insulin zinc crystalline human 100units/ml inj 10ml vials
0601012N0AAACAC
Generic insulin Insulin zinc suspension (Crystalline) Endocrine System No data available
Insulin zinc mixed bovine 100units/ml inj 10ml vials
0601012G0AAAHAH
Generic insulin Insulin zinc suspension Endocrine System No data available
Insuman Basal 100units/ml inj 3ml pre-filled OptiSet pens
0601012S0BIACAI
Insulin Insuman Basal Isophane insulin Endocrine System No data available
Insuman Comb 15 100units/ml inj 3ml pre-filled OptiSet pens
0601012D0BGAGBV
Insulin biphasic isophane (Sanofi Aventis) Biphasic isophane insulin Endocrine System No data available
Insuman Comb 15 100units/ml inj 5ml vials
0601012D0BGACBR
Insulin biphasic isophane (Sanofi Aventis) Biphasic isophane insulin Endocrine System No data available
Insuman Comb 25 100units/ml inj 3ml pre-filled OptiSet pens
0601012D0BGAHBW
Insulin biphasic isophane (Sanofi Aventis) Biphasic isophane insulin Endocrine System No data available
Insuman Comb 50 100units/ml inj 3ml pre-filled OptiSet pens
0601012D0BGAIBX
Insulin biphasic isophane (Sanofi Aventis) Biphasic isophane insulin Endocrine System No data available
Insuman Comb 50 100units/ml inj 5ml vials
0601012D0BGAEBT
Insulin biphasic isophane (Sanofi Aventis) Biphasic isophane insulin Endocrine System No data available
Insuman Infusat 100units/ml inj 10ml vials
0601011R0BCAAAD
Insulin Insuman Infusat Insulin human Endocrine System No data available
Insuman Rapid 100units/ml inj 3ml pre-filled OptiSet pens
0601011N0BKACAM
Insulin soluble (Aventis Pharma) Soluble insulin (Neutral insulin) Endocrine System No data available
Insuman Rapid 100units/ml solution for injection 5ml vials
0601011N0BKAAAW
Insulin soluble (Aventis Pharma) Soluble insulin (Neutral insulin) Endocrine System No data available
Intrinsa 300micrograms/24hours transdermal patches
0604020K0BLAABL
Intrinsa Testosterone Endocrine System No data available
Iraksin 20microgram tablets
0602010M0BHAAAA
Iraksin Liothyronine sodium Endocrine System No data available
Jinarc 15mg tablets
0605020Y0BCAAAA
Jinarc Tolvaptan Endocrine System No data available
Jinarc 30mg tablets
0605020Y0BCABAB
Jinarc Tolvaptan Endocrine System No data available
Jinarc 45mg tablets and Jinarc 15mg tablets
0605020Y0BCACAC
Jinarc Tolvaptan Endocrine System No data available
Jinarc 60mg tablets and Jinarc 30mg tablets
0605020Y0BCADAD
Jinarc Tolvaptan Endocrine System No data available
Jinarc 90mg tablets and Jinarc 30mg tablets
0605020Y0BCAEAE
Jinarc Tolvaptan Endocrine System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.